Risk factors for fingolimod-induced lymphopenia in multiple sclerosis.

Ohtani, Ryohei; Mori, Masahiro; Uchida, Tomohiko; Uzawa, Akiyuki; Masuda, Hiroki; Liu, Jia; Kuwabara, Satoshi

Ohtani, Ryohei; Mori, Masahiro; Uchida, Tomohiko; Uzawa, Akiyuki; Masuda, Hiroki; Liu, Jia; Kuwabara, Satoshi.

Afiliación

Ohtani R; Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
Uchida T; Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
Masuda H; Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
Liu J; Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Japan.

Mult Scler J Exp Transl Clin ; 4(1): 2055217318759692, 2018.

Article en En | MEDLINE | ID: mdl-29497558

Palabras clave

Fingolimod; lymphopenia; multiple sclerosis; prediction; risk factors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mult Scler J Exp Transl Clin Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google